ID: ALA4556367

Max Phase: Preclinical

Molecular Formula: C19H20ClNO

Molecular Weight: 313.83

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=C(CCc1ccc(-c2ccc(Cl)cc2)cc1)N1CCCC1

Standard InChI:  InChI=1S/C19H20ClNO/c20-18-10-8-17(9-11-18)16-6-3-15(4-7-16)5-12-19(22)21-13-1-2-14-21/h3-4,6-11H,1-2,5,12-14H2

Standard InChI Key:  KIEHFPQELRPEOU-UHFFFAOYSA-N

Associated Targets(non-human)

N-acylethanolamine-hydrolyzing acid amidase 372 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 313.83Molecular Weight (Monoisotopic): 313.1233AlogP: 4.56#Rotatable Bonds: 4
Polar Surface Area: 20.31Molecular Species: NEUTRALHBA: 1HBD: 0
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 4.35CX LogD: 4.35
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.81Np Likeness Score: -0.92

References

1. Zhou P, Xiang L, Zhao D, Ren J, Qiu Y, Li Y..  (2019)  Synthesis, biological evaluation, and structure activity relationship (SAR) study of pyrrolidine amide derivatives as N-acylethanolamine acid amidase (NAAA) inhibitors.,  10  (2): [PMID:30931090] [10.1039/C8MD00432C]

Source